• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法尼酯X受体激活通过上调库普弗细胞中的小异源二聚体伴侣来保护肝脏免受缺血/再灌注损伤。

Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.

作者信息

Jin Dan, Lu Tianfei, Ni Ming, Wang Han, Zhang Jiang, Zhong Chenpeng, Shen Chuan, Hao Jun, Busuttil Ronald W, Kupiec-Weglinski Jerzy W, Zhang Jianjun, Xu Ning, Zhai Yuan

机构信息

Department of Surgery David Geffen School of Medicine University of California Los Angles Los Angeles CA.

Department of Obstetrics and Gynecology and Shanghai Key Laboratory of Gynecologic Oncology Renji Hospital School of Medicine Shanghai Jiaotong University Shanghai China.

出版信息

Hepatol Commun. 2020 Feb 13;4(4):540-554. doi: 10.1002/hep4.1478. eCollection 2020 Apr.

DOI:10.1002/hep4.1478
PMID:32258949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7109340/
Abstract

Farnesoid X receptor (FXR) is the nuclear receptor of bile acids and is involved in innate immune regulation. FXR agonists have been shown to protect multiple organs from inflammatory tissue injuries. Because liver expresses high levels of FXR, we explored the potential therapeutic benefits and underlying mechanisms of pharmacologic FXR activation in a murine model of partial liver warm ischemia. Pretreatment of mice with FXR agonist 3-(2,6-dichlorophenyl)-4-(3'-carboxy-2-chlorostilben-4-yl)oxymethyl-5-isopropylisoxazole (GW4064) attenuated liver ischemia/reperfusion injuries (IRIs) in wild-type but not FXR knockout mice. Posttreatment with GW4064 facilitated liver recovery from IRI. Mechanistically, Kupffer cells (KCs) expressed much higher levels of FXR than bone marrow-derived macrophages (BMMs). Pretreatment of KCs but not BMMs with GW4064 resulted in lower tumor necrosis factor α but higher interleukin-10 expressions following toll-like receptor stimulation. FXR-targeted gene small heterodimer partner () was critical for the regulation of KC response by GW4064. , the depletion of KCs but not cluster of differentiation (CD) 11b cells or knockdown of diminished the immune regulatory effect of GW4064 in liver IRI. Thus, FXR activation protects liver from IRI by up-regulating in KCs to inhibit the liver proinflammatory response.

摘要

法尼酯X受体(FXR)是胆汁酸的核受体,参与固有免疫调节。FXR激动剂已被证明可保护多个器官免受炎症组织损伤。由于肝脏中FXR表达水平较高,我们在部分肝脏热缺血的小鼠模型中探索了药物性激活FXR的潜在治疗益处及潜在机制。用FXR激动剂3-(2,6-二氯苯基)-4-(3'-羧基-2-氯芪-4-基)氧甲基-5-异丙基异恶唑(GW4064)预处理小鼠可减轻野生型小鼠而非FXR基因敲除小鼠的肝脏缺血/再灌注损伤(IRI)。用GW4064进行后处理促进了肝脏从IRI中恢复。机制上,库普弗细胞(KC)中FXR的表达水平远高于骨髓来源的巨噬细胞(BMM)。用GW4064预处理KC而非BMM,在 toll样受体刺激后导致肿瘤坏死因子α表达降低但白细胞介素-10表达升高。FXR靶向基因小异二聚体伴侣(SHP)对于GW4064调节KC反应至关重要。此外,清除KC而非分化簇(CD)11b细胞或敲低SHP可减弱GW4064在肝脏IRI中的免疫调节作用。因此,激活FXR通过上调KC中的SHP来抑制肝脏促炎反应,从而保护肝脏免受IRI损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/adbc595909ee/HEP4-4-540-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/a134ffa606d8/HEP4-4-540-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/6a926fd7f3c4/HEP4-4-540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/b6b4b687d587/HEP4-4-540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/e724a4430d6c/HEP4-4-540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/b44bb724546d/HEP4-4-540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/c06d67d6904b/HEP4-4-540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/adbc595909ee/HEP4-4-540-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/a134ffa606d8/HEP4-4-540-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/6a926fd7f3c4/HEP4-4-540-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/b6b4b687d587/HEP4-4-540-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/e724a4430d6c/HEP4-4-540-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/b44bb724546d/HEP4-4-540-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/c06d67d6904b/HEP4-4-540-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f736/7109340/adbc595909ee/HEP4-4-540-g007.jpg

相似文献

1
Farnesoid X Receptor Activation Protects Liver From Ischemia/Reperfusion Injury by Up-Regulating Small Heterodimer Partner in Kupffer Cells.法尼酯X受体激活通过上调库普弗细胞中的小异源二聚体伴侣来保护肝脏免受缺血/再灌注损伤。
Hepatol Commun. 2020 Feb 13;4(4):540-554. doi: 10.1002/hep4.1478. eCollection 2020 Apr.
2
GW4064, an agonist of farnesoid X receptor, represses CYP3A4 expression in human hepatocytes by inducing small heterodimer partner expression.GW4064,一种法尼醇X受体激动剂,通过诱导小异二聚体伴侣表达来抑制人肝细胞中CYP3A4的表达。
Drug Metab Dispos. 2015 May;43(5):743-8. doi: 10.1124/dmd.114.062836. Epub 2015 Feb 27.
3
Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation.糖原合酶激酶 3β通过抑制 AMP 激活的蛋白激酶激活促进肝脏固有免疫激活。
J Hepatol. 2018 Jul;69(1):99-109. doi: 10.1016/j.jhep.2018.01.036. Epub 2018 Feb 13.
4
Farnesoid X Receptor Agonist Represses Cytochrome P450 2D6 Expression by Upregulating Small Heterodimer Partner.法尼醇X受体激动剂通过上调小异二聚体伴侣来抑制细胞色素P450 2D6的表达。
Drug Metab Dispos. 2015 Jul;43(7):1002-7. doi: 10.1124/dmd.115.064758. Epub 2015 Apr 29.
5
Small heterodimer partner overexpression partially protects against liver tumor development in farnesoid X receptor knockout mice.小异二聚体伴侣过表达部分保护法尼醇 X 受体敲除小鼠肝肿瘤的发生。
Toxicol Appl Pharmacol. 2013 Oct 15;272(2):299-305. doi: 10.1016/j.taap.2013.06.016. Epub 2013 Jun 26.
6
Farnesoid X receptor signaling activates the hepatic X-box binding protein 1 pathway in vitro and in mice.法尼醇 X 受体信号在体外和小鼠中激活肝 X 盒结合蛋白 1 途径。
Hepatology. 2018 Jul;68(1):304-316. doi: 10.1002/hep.29815. Epub 2018 May 10.
7
Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis.FXR-p62/SQSTM1通路对小鼠肝细胞和肝脏(尤其是脂肪变性的肝脏)存活与保护的相关性。
BMC Gastroenterol. 2017 Jan 13;17(1):9. doi: 10.1186/s12876-016-0568-3.
8
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.法尼酯X受体,即胆汁酸传感核受体,与肝脏再生。
Acta Pharm Sin B. 2015 Mar;5(2):93-8. doi: 10.1016/j.apsb.2015.01.005. Epub 2015 Feb 20.
9
Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.GW4064短期激活法尼醇X受体(Fxr)后,妊娠小鼠肝肠胆汁酸途径的恢复
Toxicol Appl Pharmacol. 2016 Nov 1;310:60-67. doi: 10.1016/j.taap.2016.08.021. Epub 2016 Sep 5.
10
FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.法尼醇X受体激动剂GW4064通过抑制巨噬细胞活化减轻内毒素诱导的肝脏炎症。
World J Gastroenterol. 2014 Oct 21;20(39):14430-41. doi: 10.3748/wjg.v20.i39.14430.

引用本文的文献

1
Nuclear receptor FXR inhibits ferroptosis to alleviate hepatic ischemia-reperfusion injury by targeting GPX4 in a mouse model.在小鼠模型中,核受体FXR通过靶向GPX4抑制铁死亡以减轻肝脏缺血再灌注损伤。
J Mol Histol. 2025 Jul 31;56(4):243. doi: 10.1007/s10735-025-10534-z.
2
Phenotyping the Chemical Communications of the Intestinal Microbiota and the Host: Secondary Bile Acids as Postbiotics.肠道微生物群与宿主化学通讯的表型分析:次级胆汁酸作为益生元后体。
Cells. 2025 Apr 15;14(8):595. doi: 10.3390/cells14080595.
3
Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets.

本文引用的文献

1
Bile Acids Activated Receptors Regulate Innate Immunity.胆汁酸激活受体调节先天免疫。
Front Immunol. 2018 Aug 13;9:1853. doi: 10.3389/fimmu.2018.01853. eCollection 2018.
2
Glycogen synthase kinase 3β promotes liver innate immune activation by restraining AMP-activated protein kinase activation.糖原合酶激酶 3β通过抑制 AMP 激活的蛋白激酶激活促进肝脏固有免疫激活。
J Hepatol. 2018 Jul;69(1):99-109. doi: 10.1016/j.jhep.2018.01.036. Epub 2018 Feb 13.
3
The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury.
健康与疾病中的胆汁酸代谢及信号传导:分子机制与治疗靶点
Signal Transduct Target Ther. 2024 Apr 26;9(1):97. doi: 10.1038/s41392-024-01811-6.
4
Farnesoid X receptor: From Structure to Function and Its Pharmacology in Liver Fibrosis.法尼醇 X 受体:从结构到功能及其在肝纤维化中的药理学。
Aging Dis. 2024 Aug 1;15(4):1508-1536. doi: 10.14336/AD.2023.0830.
5
Small Heterodimer Partner Modulates Macrophage Differentiation during Innate Immune Response through the Regulation of Peroxisome Proliferator Activated Receptor Gamma, Mitogen-Activated Protein Kinase, and Nuclear Factor Kappa B Pathways.小异源二聚体伴侣通过调节过氧化物酶体增殖物激活受体γ、丝裂原活化蛋白激酶和核因子κB信号通路,在天然免疫应答过程中调控巨噬细胞分化。
Biomedicines. 2023 Aug 28;11(9):2403. doi: 10.3390/biomedicines11092403.
6
Updates on the Immune Cell Basis of Hepatic Ischemia-Reperfusion Injury.肝缺血再灌注损伤的免疫细胞基础研究进展。
Mol Cells. 2023 Sep 30;46(9):527-534. doi: 10.14348/molcells.2023.0099. Epub 2023 Aug 22.
7
Cell metabolism-based therapy for liver fibrosis, repair, and hepatocellular carcinoma.基于细胞代谢的肝纤维化、修复及肝细胞癌治疗方法。
Hepatology. 2025 Jan 1;81(1):269-287. doi: 10.1097/HEP.0000000000000479. Epub 2023 May 23.
8
Targeting the Hepatic Microenvironment to Improve Ischemia/Reperfusion Injury: New Insights into the Immune and Metabolic Compartments.靶向肝脏微环境以改善缺血/再灌注损伤:免疫和代谢区室的新见解
Aging Dis. 2022 Jul 11;13(4):1196-1214. doi: 10.14336/AD.2022.0109.
9
Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms.甘草次酸通过利胆和抗炎机制对石胆酸诱导的胆汁淤积性肝损伤的肝保护作用
Front Pharmacol. 2022 May 31;13:881231. doi: 10.3389/fphar.2022.881231. eCollection 2022.
10
Antibiotic pretreatment attenuates liver ischemia-reperfusion injury by Farnesoid X receptor activation.抗生素预处理通过法尼醇 X 受体激活减轻肝缺血再灌注损伤。
Cell Death Dis. 2022 May 21;13(5):484. doi: 10.1038/s41419-022-04955-x.
法尼醇X受体激动剂奥贝胆酸在肝缺血/再灌注损伤期间通过多药及毒素外排蛋白1(MATE-1)上调不对称二甲基精氨酸的胆汁排泄。
PLoS One. 2018 Jan 18;13(1):e0191430. doi: 10.1371/journal.pone.0191430. eCollection 2018.
4
Interactions between bile salts, gut microbiota, and hepatic innate immunity.胆汁盐、肠道微生物群和肝脏先天免疫之间的相互作用。
Immunol Rev. 2017 Sep;279(1):23-35. doi: 10.1111/imr.12579.
5
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage.法尼醇 X 受体激活可保护肾脏免受缺血再灌注损伤。
Sci Rep. 2017 Aug 29;7(1):9815. doi: 10.1038/s41598-017-10168-6.
6
Small heterodimer partner deletion prevents hepatic steatosis and when combined with farnesoid X receptor loss protects against type 2 diabetes in mice.小异二聚体伴侣缺失可预防肝脏脂肪变性,与法尼酯X受体缺失联合使用时可预防小鼠2型糖尿病。
Hepatology. 2017 Dec;66(6):1854-1865. doi: 10.1002/hep.29305. Epub 2017 Oct 30.
7
Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis.法尼醇X受体对NLRP3炎性小体的调节是胆汁淤积相关性脓毒症的基础。
Cell Metab. 2017 Apr 4;25(4):856-867.e5. doi: 10.1016/j.cmet.2017.03.007.
8
Prolonged Ischemia Triggers Necrotic Depletion of Tissue-Resident Macrophages To Facilitate Inflammatory Immune Activation in Liver Ischemia Reperfusion Injury.长时间缺血引发组织驻留巨噬细胞的坏死性消耗,以促进肝缺血再灌注损伤中的炎性免疫激活。
J Immunol. 2017 May 1;198(9):3588-3595. doi: 10.4049/jimmunol.1601428. Epub 2017 Mar 13.
9
Farnesoid X Receptor Activation Attenuates Intestinal Ischemia Reperfusion Injury in Rats.法尼酯X受体激活减轻大鼠肠道缺血再灌注损伤
PLoS One. 2017 Jan 6;12(1):e0169331. doi: 10.1371/journal.pone.0169331. eCollection 2017.
10
Bile Acid Nuclear Receptor Farnesoid X Receptor: Therapeutic Target for Nonalcoholic Fatty Liver Disease.胆汁酸核受体法尼醇X受体:非酒精性脂肪性肝病的治疗靶点
Endocrinol Metab (Seoul). 2016 Dec;31(4):500-504. doi: 10.3803/EnM.2016.31.4.500.